Two-Stage Amplifier Coupling two enzymatic reactions: sensitive detection for immunological ELISA tests
Bioanalytical and diagnostic test methods are often based on the recognition of biomolecules by other biomolecules. However, biochemical events such as these are not directly detectable and must first be converted into physical signals, for example an electrical or optical signal. Since transient and minute amounts of substance are usually involved, which must be detected in very small test volumes, an effective "amplifier" must be employed. Enzyme reactions are a good choice as amplifiers and signal transformers: a single enzyme molecule generates a large number of detectable (e.g. fluorescent) molecules, which can be detected easily. This principle is also the basis of a well-established method, the enzyme-labeled immunosorbant assay (ELISA).
Researchers in Jerusalem have now developed a new ELISA protocol that utilizes two successive enzyme reactions. Enzyme 1 produces many copies of enzyme 2, which in turn produces many copies of a detectable fluorescent dye. In this way, the amplification effect is increased, and the assay is much more sensitive. The research group of Itamar Willner has used this new protocol to develop an ELISA test for telomerase, an important cancer marker. In comparison with traditional telomerase assays, the new method is considerably simpler, more efficient, and more sensitive.
This is how it works: Anti-telomerase antibodies are immobilized on a carrier, to which the test sample is added. The telomerase in the sample adheres to the antibodies. In the next step, another telomerase antibody is added, which recognizes the bound telomerase and binds to it. The trick: this second antibody is fitted with a binding site for a molecular "adaptor". An ecarin enzyme fitted with such an adapter can thus bind to it. Now, the two-stage amplifier can kick in: ecarin converts added prothrombin into thrombin (a reaction that incidentally plays a role in blood clotting). Thrombin is a biocatalyst that is able to liberate the fluorescent dye rhodamine from a nonfluorescent precursor. By measuring the fluorescence, the researchers were able to detect the telomerase from only 1000 cancer cells-an amount that is not detectable using previous detection methods.
The method of nonlinear amplification through coupled enzyme reactions is not only suitable for immunoassays but also for the detection of specific DNA sequences.
Other news from the department science
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
